pubmed.ncbi.nlm.nih.gov

Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces - PubMed

Review

Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces

Fabíola Costa et al. Acta Biomater. 2011 Apr.

Abstract

Bacterial adhesion to biomaterials remains a major problem in the medical devices field. Antimicrobial peptides (AMPs) are well-known components of the innate immune system that can be applied to overcome biofilm-associated infections. Their relevance has been increasing as a practical alternative to conventional antibiotics, which are declining in effectiveness. The recent interest focused on these peptides can be explained by a group of special features, including a wide spectrum of activity, high efficacy at very low concentrations, target specificity, anti-endotoxin activity, synergistic action with classical antibiotics, and low propensity for developing resistance. Therefore, the development of an antimicrobial coating with such properties would be worthwhile. The immobilization of AMPs onto a biomaterial surface has further advantages as it also helps to circumvent AMPs' potential limitations, such as short half-life and cytotoxicity associated with higher concentrations of soluble peptides. The studies discussed in the current review report on the impact of covalent immobilization of AMPs onto surfaces through different chemical coupling strategies, length of spacers, and peptide orientation and concentration. The overall results suggest that immobilized AMPs may be effective in the prevention of biofilm formation by reduction of microorganism survival post-contact with the coated biomaterial. Minimal cytotoxicity and long-term stability profiles were obtained by optimizing immobilization parameters, indicating a promising potential for the use of immobilized AMPs in clinical applications. On the other hand, the effects of tethering on mechanisms of action of AMPs have not yet been fully elucidated. Therefore, further studies are recommended to explore the real potential of immobilized AMPs in health applications as antimicrobial coatings of medical devices.

PubMed Disclaimer

Cited by

Escherichia coli resistance to nonbiocidal antibiofilm polysaccharides is rare and mediated by multiple mutations leading to surface physicochemical modifications.
Travier L, Rendueles O, Ferrières L, Herry JM, Ghigo JM. Travier L, et al. Antimicrob Agents Chemother. 2013 Aug;57(8):3960-8. doi: 10.1128/AAC.02606-12. Epub 2013 Jun 3. Antimicrob Agents Chemother. 2013. PMID: 23733462 Free PMC article.
Combinatorial discovery of polymers resistant to bacterial attachment.
Hook AL, Chang CY, Yang J, Luckett J, Cockayne A, Atkinson S, Mei Y, Bayston R, Irvine DJ, Langer R, Anderson DG, Williams P, Davies MC, Alexander MR. Hook AL, et al. Nat Biotechnol. 2012 Sep;30(9):868-875. doi: 10.1038/nbt.2316. Nat Biotechnol. 2012. PMID: 22885723 Free PMC article.
Dual mode antibacterial activity of ion substituted calcium phosphate nanocarriers for bone infections.
Sampath Kumar TS, Madhumathi K, Rubaiya Y, Doble M. Sampath Kumar TS, et al. Front Bioeng Biotechnol. 2015 May 1;3:59. doi: 10.3389/fbioe.2015.00059. eCollection 2015. Front Bioeng Biotechnol. 2015. PMID: 25984512 Free PMC article.
Blood Compatibility-An Important but Often Forgotten Aspect of the Characterization of Antimicrobial Peptides for Clinical Application.
Harm S, Lohner K, Fichtinger U, Schildböck C, Zottl J, Hartmann J. Harm S, et al. Int J Mol Sci. 2019 Oct 31;20(21):5426. doi: 10.3390/ijms20215426. Int J Mol Sci. 2019. PMID: 31683553 Free PMC article.
Bactericidal and Bioresorbable Calcium Phosphate Cements Fabricated by Silver-Containing Tricalcium Phosphate Microspheres.
Honda M, Kawanobe Y, Nagata K, Ishii K, Matsumoto M, Aizawa M. Honda M, et al. Int J Mol Sci. 2020 May 26;21(11):3745. doi: 10.3390/ijms21113745. Int J Mol Sci. 2020. PMID: 32466460 Free PMC article.

Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces - PubMed